Patient-Prosthesis Mismatch in Aortic Valve Replacement With No.19 Prosthesis: Impact on Early and Late Outcomes

主动脉瓣置换术中19号人工瓣膜患者-人工瓣膜不匹配:对早期和晚期结果的影响

阅读:1

Abstract

INTRODUCTION: Patient-prosthesis mismatch (PPM) continues to be a crucial topic of discussion regarding its influence on the aortic valve surgery results. The aim of our study is to evaluate the incidence of mismatch and its influence on early and late results in aortic valve replacement using prosthesis No 19. METHODS: A cohort of 175 patients underwent aortic valve replacement with prosthesis No-19 and was followed for up to 10 years. PPM was defined according to indexed effective orifice valve area (EOAi). Early results were evaluated through hospital mortality, and the data were collected from hospital recordings. Long-term follow-up was realized by contacting the patients by phone. The endpoints were mortality and the clinical status assessed by New York Heart Association (NYHA) class change after intervention. RESULTS: The overall and severe mismatch incidence was 69.1% and 29.7%, respectively. Overall, hospital mortality is 3.4%. Severe mismatch (p=0.057) and continuous values of indexed effective orifice area (p = 0.079), adjusted for sex and age, do not affect early mortality. Severe mismatch and indexed effective orifice area were associated with less post-operative improvement of NYHA functional class (p<0.015) in the long term, independently from other predictors. CONCLUSIONS: Severe mismatch and small indexed orifice areas do not affect early and late mortality, but they are related, importantly, with less symptomatic improvement in the long-term outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。